**Author details**

Kunihiko Hiraiwa and Stephan F. van Eeden\*

\*Address all correspondence to: stephan.vaneeden@hli.ubc.ca

Department of Medicine, UBC James Hogg Research Centre, St. Paul's Hospital, University of British Columbia, Vancouver, Canada

#### **References**

[1] Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med. 2000 May 4;342(18):1334-49.

[2] Matthay MA, Zimmerman GA. Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management. Am J Respir Cell Mol Biol. 2005 Oct;33(4):319-27.

[18] American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of in‐

Nature and Consequences of the Systemic Inflammatory Response Induced by Lung Inflammation

http://dx.doi.org/10.5772/57392

99

[19] Goris RJ, te Boekhorst TP, Nuytinck JK, Gimbrere JS. Multiple-organ failure. General‐

[20] Opitz B, van Laak V, Eitel J, Suttorp N. Innate immune recognition in infectious and noninfectious diseases of the lung. Am J Respir Crit Care Med. 2010 Jun 15;181(12):

[21] Windsor AC, Walsh CJ, Mullen PG, Cook DJ, Fisher BJ, Blocher CR, et al. Tumor ne‐ crosis factor-alpha blockade prevents neutrophil CD18 receptor upregulation and at‐ tenuates acute lung injury in porcine sepsis without inhibition of neutrophil oxygen

[22] Friedman GD, Klatsky AL, Siegelaub AB. The leukocyte count as a predictor of myo‐

[23] Grimm RH, Jr., Neaton JD, Ludwig W. Prognostic importance of the white blood cell count for coronary, cancer, and all-cause mortality. JAMA. 1985 Oct 11;254(14):

[24] Weiss ST, Segal MR, Sparrow D, Wager C. Relation of FEV1 and peripheral blood leukocyte count to total mortality. The Normative Aging Study. Am J Epidemiol.

[25] Corre F, Lellouch J, Schwartz D. Smoking and leucocyte-counts. Results of an epide‐

[26] Chan-Yeung M, Abboud R, Buncio AD, Vedal S. Peripheral leucocyte count and lon‐

[27] van Eeden SF, Hogg JC. The response of human bone marrow to chronic cigarette

[28] Terashima T, Wiggs B, English D, Hogg JC, van Eeden SF. The effect of cigarette smoking on the bone marrow. Am J Respir Crit Care Med. 1997 Mar;155(3):1021-6.

[29] Torres JL, Ridker PM. Clinical use of high sensitivity C-reactive protein for the pre‐ diction of adverse cardiovascular events. Curr Opin Cardiol. 2003 Nov;18(6):471-8.

[30] Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at in‐ creased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation. 2003 Mar 25;107(11):1514-9.

[31] Shaaban R, Kony S, Driss F, Leynaert B, Soussan D, Pin I, et al. Change in C-reactive protein levels and FEV1 decline: a longitudinal population-based study. Respir Med.

ized autodestructive inflammation? Arch Surg. 1985 Oct;120(10):1109-15.

novative therapies in sepsis. Crit Care Med. 1992 Jun;20(6):864-74.

radical generation. J Clin Invest. 1993 Apr;91(4):1459-68.

cardial infarction. N Engl J Med. 1974 Jun 6;290(23):1275-8.

1995 Sep 1;142(5):493-8; discussion 9-503.

miological survey. Lancet. 1971 Sep 18;2(7725):632-4.

smoking. Eur Respir J. 2000 May;15(5):915-21.

2006 Dec;100(12):2112-20.

gitudinal decline in lung function. Thorax. 1988 Jun;43(6):462-6.

1294-309.

1932-7.


[18] American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of in‐ novative therapies in sepsis. Crit Care Med. 1992 Jun;20(6):864-74.

[2] Matthay MA, Zimmerman GA. Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management. Am J

[3] Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, et al. Incidence and outcomes of acute lung injury. N Engl J Med. 2005 Oct 20;353(16):1685-93.

[4] Girdhar A, Kumar V, Singh A, Menon B, Vijayan VK. Systemic inflammation and its response to treatment in patients with asthma. Respir Care. 2011 Jun;56(6):800-5. [5] Jousilahti P, Salomaa V, Hakala K, Rasi V, Vahtera E, Palosuo T. The association of sensitive systemic inflammation markers with bronchial asthma. Ann Allergy Asth‐

[6] Olafsdottir IS, Gislason T, Thjodleifsson B, Olafsson I, Gislason D, Jogi R, et al. C re‐ active protein levels are increased in non-allergic but not allergic asthma: a multicen‐

[7] Takemura M, Matsumoto H, Niimi A, Ueda T, Matsuoka H, Yamaguchi M, et al. High sensitivity C-reactive protein in asthma. Eur Respir J. 2006 May;27(5):908-12. [8] Wilson CB, Jones PW, O'Leary CJ, Hansell DM, Dowling RB, Cole PJ, et al. Systemic markers of inflammation in stable bronchiectasis. Eur Respir J. 1998 Oct;12(4):820-4.

[9] Martinez-Garcia MA, Perpina-Tordera M, Roman-Sanchez P, Soler-Cataluna JJ, Car‐ ratala A, Yago M, et al. [The association between bronchiectasis, systemic inflamma‐ tion, and tumor necrosis factor alpha]. Arch Bronconeumol. 2008 Jan;44(1):8-14. [10] Weinrib L, Sharma OP, Quismorio FP, Jr. A long-term study of interstitial lung dis‐ ease in systemic lupus erythematosus. Semin Arthritis Rheum. 1990 Aug;20(1):48-56.

[11] Hamblin MJ, Horton MR. Rheumatoid arthritis-associated interstitial lung disease:

[12] Fischer A, du Bois R. Interstitial lung disease in connective tissue disorders. Lancet.

[13] Solomon JJ, Olson AL, Fischer A, Bull T, Brown KK, Raghu G. Scleroderma lung dis‐

[14] Castelino FV, Varga J. Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and management. Arthritis Res Ther. 2010;12(4):213.

[15] Matthay MA, Ware LB, Zimmerman GA. The acute respiratory distress syndrome. J

[17] Klune JR, Tsung A. Molecular biology of liver ischemia/reperfusion injury: establish‐ ed mechanisms and recent advancements. Surg Clin North Am. 2010 Aug;90(4):

Respir Cell Mol Biol. 2005 Oct;33(4):319-27.

98 Lung Inflammation

ma Immunol. 2002 Oct;89(4):381-5.

tre epidemiological study. Thorax. 2005 Jun;60(6):451-4.

diagnostic dilemma. Pulm Med. 2011;2011:872120.

ease. Eur Respir Rev. 2013 Mar 1;22(127):6-19.

[16] Fry DE. Sepsis syndrome. Am Surg. 2000 Feb;66(2):126-32.

Clin Invest. 2012 Aug 1;122(8):2731-40.

665-77.

2012 Aug 18;380(9842):689-98.


[32] Pinto-Plata VM, Mullerova H, Toso JF, Feudjo-Tepie M, Soriano JB, Vessey RS, et al. C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax. 2006 Jan;61(1):23-8.

[44] Tan WC, Qiu D, Liam BL, Ng TP, Lee SH, van Eeden SF, et al. The human bone mar‐ row response to acute air pollution caused by forest fires. Am J Respir Crit Care Med.

Nature and Consequences of the Systemic Inflammatory Response Induced by Lung Inflammation

http://dx.doi.org/10.5772/57392

101

[45] van Eeden SF, Tan WC, Suwa T, Mukae H, Terashima T, Fujii T, et al. Cytokines in‐ volved in the systemic inflammatory response induced by exposure to particulate matter air pollutants (PM(10)). Am J Respir Crit Care Med. 2001 Sep 1;164(5):826-30.

[46] Vincent R, Bjarnason SG, Adamson IY, Hedgecock C, Kumarathasan P, Guenette J, et al. Acute pulmonary toxicity of urban particulate matter and ozone. Am J Pathol.

[47] Fujii T, Hayashi S, Hogg JC, Vincent R, Van Eeden SF. Particulate matter induces cy‐ tokine expression in human bronchial epithelial cells. Am J Respir Cell Mol Biol. 2001

[48] Boland S, Baeza-Squiban A, Fournier T, Houcine O, Gendron MC, Chevrier M, et al. Diesel exhaust particles are taken up by human airway epithelial cells in vitro and

[49] Hashimoto S, Gon Y, Matsumoto K, Takeshita I, Maruoka S, Horie T. Inhalant corti‐ costeroids inhibit hyperosmolarity-induced, and cooling and rewarming-induced in‐ terleukin-8 and RANTES production by human bronchial epithelial cells. Am J

[50] Fujii T, Hayashi S, Hogg JC, Mukae H, Suwa T, Goto Y, et al. Interaction of alveolar macrophages and airway epithelial cells following exposure to particulate matter produces mediators that stimulate the bone marrow. Am J Respir Cell Mol Biol. 2002

[51] Al Lawati N, Mulgrew A, Cheema R, vanEeden S, Butt A, Fleetham J, et al. Pro-athe‐ rogenic cytokine profile of patients with suspected obstructive sleep apnea. Sleep

[52] Bruno A, Alessi M, Soresi S, Bonanno A, Riccobono L, Montalbano AM, et al. In‐ creased leptin/leptin receptor pathway affects systemic and airway inflammation in

[53] Bijanzadeh M, Ramachandra NB, Mahesh PA, Savitha MR, Vijayakumar GS, Kumar P, et al. Soluble intercellular adhesion molecule-1 and E-selectin in patients with

[54] Friedman J, Goldberg H, Horvath TB, Meares RA. The effect of tobacco smoking on evoked potentials. Clin Exp Pharmacol Physiol. 1974 May-Jun;1(3):249-58.

[55] Friedman J, Horvath T, Meares R. Tobacco smoking and a 'stimulus barrier'. Nature.

alter cytokine production. Am J Physiol. 1999 Apr;276(4 Pt 1):L604-13.

Respir Crit Care Med. 2000 Sep;162(3 Pt 1):1075-80.

COPD former smokers. J Inflamm Res. 2011;4:51-9.

asthma exacerbation. Lung. 2009 Sep-Oct;187(5):315-20.

2000 Apr;161(4 Pt 1):1213-7.

1997 Dec;151(6):1563-70.

Sep;25(3):265-71.

Jul;27(1):34-41.

Breath. 2009 Nov;13(4):391-5.

1974 Mar 29;248(447):455-6.


[44] Tan WC, Qiu D, Liam BL, Ng TP, Lee SH, van Eeden SF, et al. The human bone mar‐ row response to acute air pollution caused by forest fires. Am J Respir Crit Care Med. 2000 Apr;161(4 Pt 1):1213-7.

[32] Pinto-Plata VM, Mullerova H, Toso JF, Feudjo-Tepie M, Soriano JB, Vessey RS, et al. C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax.

[33] Sin DD, Lacy P, York E, Man SF. Effects of fluticasone on systemic markers of inflam‐ mation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004

[34] Chung KF. Cytokines in chronic obstructive pulmonary disease. Eur Respir J Suppl.

[35] Eid AA, Ionescu AA, Nixon LS, Lewis-Jenkins V, Matthews SB, Griffiths TL, et al. In‐ flammatory response and body composition in chronic obstructive pulmonary dis‐

[36] Di Francia M, Barbier D, Mege JL, Orehek J. Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med.

[37] Gustafsson A, Asman B, Bergstrom K. Cigarette smoking as an aggravating factor in inflammatory tissue-destructive diseases. Increase in tumor necrosis Factor-alpha priming of peripheral neutrophils measured as generation of oxygen radicals. Int J

[38] Noguera A, Batle S, Miralles C, Iglesias J, Busquets X, MacNee W, et al. Enhanced neutrophil response in chronic obstructive pulmonary disease. Thorax. 2001 Jun;

[39] de Godoy I, Donahoe M, Calhoun WJ, Mancino J, Rogers RM. Elevated TNF-alpha production by peripheral blood monocytes of weight-losing COPD patients. Am J

[40] Schols AM, Buurman WA, Staal van den Brekel AJ, Dentener MA, Wouters EF. Evi‐ dence for a relation between metabolic derangements and increased levels of inflam‐ matory mediators in a subgroup of patients with chronic obstructive pulmonary

[41] Dentener MA, Creutzberg EC, Schols AM, Mantovani A, van't Veer C, Buurman WA, et al. Systemic anti-inflammatory mediators in COPD: increase in soluble interleukin

[42] Terashima T, Wiggs B, English D, Hogg JC, van Eeden SF. Phagocytosis of small car‐ bon particles (PM10) by alveolar macrophages stimulates the release of polymorpho‐ nuclear leukocytes from bone marrow. Am J Respir Crit Care Med. 1997 Apr;155(4):

[43] Mukae H, Vincent R, Quinlan K, English D, Hards J, Hogg JC, et al. The effect of re‐ peated exposure to particulate air pollution (PM10) on the bone marrow. Am J Respir

1 receptor II during treatment of exacerbations. Thorax. 2001 Sep;56(9):721-6.

ease. Am J Respir Crit Care Med. 2001 Oct 15;164(8 Pt 1):1414-8.

2006 Jan;61(1):23-8.

100 Lung Inflammation

Oct 1;170(7):760-5.

2001 Dec;34:50s-9s.

1994 Nov;150(5 Pt 1):1453-5.

Clin Lab Res. 2000;30(4):187-90.

Respir Crit Care Med. 1996 Feb;153(2):633-7.

disease. Thorax. 1996 Aug;51(8):819-24.

Crit Care Med. 2001 Jan;163(1):201-9.

56(6):432-7.

1441-7.


[56] van Eeden SF, Granton J, Hards JM, Moore B, Hogg JC. Expression of the cell adhe‐ sion molecules on leukocytes that demarginate during acute maximal exercise. J Appl Physiol. 1999 Mar;86(3):970-6.

[69] Heinrich J, Assmann G. Fibrinogen and cardiovascular risk. J Cardiovasc Risk. 1995

Nature and Consequences of the Systemic Inflammatory Response Induced by Lung Inflammation

http://dx.doi.org/10.5772/57392

103

[70] Haverkate F, Thompson SG, Pyke SD, Gallimore JR, Pepys MB. Production of C-reac‐ tive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lan‐

[71] Tracy RP, Lemaitre RN, Psaty BM, Ives DG, Evans RW, Cushman M, et al. Relation‐ ship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arte‐

[72] Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, as‐ pirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J

[73] Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reac‐ tive protein and the risk of future cardiovascular events among apparently healthy

[74] Mire-Sluis A, Thorpe R. Quality considerations for recombinant DNA-derived bio‐ logical therapeutic products: a control perspective on cytokines. BioDrugs. 1999 Jun;

[75] Topham MK, Carveth HJ, McIntyre TM, Prescott SM, Zimmerman GA. Human en‐ dothelial cells regulate polymorphonuclear leukocyte degranulation. FASEB J. 1998

[76] Mire-Sluis AR. Analytical characterisation of cytokines and growth factors. Dev Biol

[77] Mackiewicz A, Laciak M, Gorny A, Baumann H. Leukemia inhibitory factor, interfer‐ on gamma and dexamethasone regulate N-glycosylation of alpha 1-protease inhibi‐

[78] Suwa T, Hogg JC, Klut ME, Hards J, van Eeden SF. Interleukin-6 changes deformabil‐ ity of neutrophils and induces their sequestration in the lung. Am J Respir Crit Care

[79] Schaaf BM, Boehmke F, Esnaashari H, Seitzer U, Kothe H, Maass M, et al. Pneumo‐ coccal septic shock is associated with the interleukin-10-1082 gene promoter poly‐

[80] Shu Q, Fang X, Chen Q, Stuber F. IL-10 polymorphism is associated with increased

[81] Rautou PE, Vion AC, Amabile N, Chironi G, Simon A, Tedgui A, et al. Microparti‐ cles, vascular function, and atherothrombosis. Circ Res. 2011 Aug 19;109(5):593-606.

tor in human hepatoma cells. Eur J Cell Biol. 1993 Apr;60(2):331-6.

morphism. Am J Respir Crit Care Med. 2003 Aug 15;168(4):476-80.

incidence of severe sepsis. Chin Med J (Engl). 2003 Nov;116(11):1756-9.

Jun;2(3):197-205.

cet. 1997 Feb 15;349(9050):462-6.

Med. 1997 Apr 3;336(14):973-9.

11(6):367-76.

Jun;12(9):733-46.

Stand. 1999;97:3-9.

Med. 2001 Mar;163(4):970-6.

rioscler Thromb Vasc Biol. 1997 Jun;17(6):1121-7.

women. Circulation. 1998 Aug 25;98(8):731-3.


[69] Heinrich J, Assmann G. Fibrinogen and cardiovascular risk. J Cardiovasc Risk. 1995 Jun;2(3):197-205.

[56] van Eeden SF, Granton J, Hards JM, Moore B, Hogg JC. Expression of the cell adhe‐ sion molecules on leukocytes that demarginate during acute maximal exercise. J

[57] Terashima T, Amakawa K, Matsumaru A, van Eeden S, Hogg JC, Yamaguchi K. BAL induces an increase in peripheral blood neutrophils and cytokine levels in healthy

[58] Muchmore HG, Blackburn AB, Shurley JT, Pierce CM, McKown BA. Neutropenia in healthy men at the South Polar Plateau. Arch Intern Med. 1970 Apr;125(4):646-8.

[59] Sakai M, Sato Y, Sato S, Ihara S, Onizuka M, Sakakibara Y, et al. Effect of relocating to areas of reduced atmospheric particulate matter levels on the human circulating leu‐

[60] Bicknell S, van Eeden S, Hayashi S, Hards J, English D, Hogg JC. A non-radioisotopic method for tracing neutrophils in vivo using 5'-bromo-2'-deoxyuridine. Am J Respir

[61] Terashima T, Wiggs B, English D, Hogg JC, van Eeden SF. Polymorphonuclear leuko‐ cyte transit times in bone marrow during streptococcal pneumonia. Am J Physiol.

[62] Goto Y, Hogg JC, Suwa T, Quinlan KB, van Eeden SF. A novel method to quantify the turnover and release of monocytes from the bone marrow using the thymidine analog 5'-bromo-2'-deoxyuridine. Am J Physiol Cell Physiol. 2003 Aug;285(2):C253-9.

[63] Terashima T, Klut ME, English D, Hards J, Hogg JC, van Eeden SF. Cigarette smok‐ ing causes sequestration of polymorphonuclear leukocytes released from the bone

[64] Goto Y, Hogg JC, Shih CH, Ishii H, Vincent R, van Eeden SF. Exposure to ambient particles accelerates monocyte release from bone marrow in atherosclerotic rabbits.

[65] Lawrence E, Van Eeden S, English D, Hogg JC. Polymorphonuclear leukocyte (PMN) migration in streptococcal pneumonia: comparison of older PMN with those recently

[66] van Eeden SF, Kitagawa Y, Sato Y, Hogg JC. Polymorphonuclear leukocytes released from the bone marrow and acute lung injury. Chest. 1999 Jul;116(1 Suppl):43S-6S.

[67] van Eeden SF, Lawrence E, Sato Y, Kitagawa Y, Hogg JC. Neutrophils released from the bone marrow by granulocyte colony-stimulating factor sequester in lung micro‐

[68] Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflam‐

vessels but are slow to migrate. Eur Respir J. 2000 Jun;15(6):1079-86.

mation. N Engl J Med. 1999 Feb 11;340(6):448-54.

released from the marrow. Am J Respir Cell Mol Biol. 1996 Mar;14(3):217-24.

marrow in lung microvessels. Am J Respir Cell Mol Biol. 1999 Jan;20(1):171-7.

Am J Physiol Lung Cell Mol Physiol. 2004 Jul;287(1):L79-85.

volunteers and patients with pneumonia. Chest. 2001 Jun;119(6):1724-9.

kocyte count. J Appl Physiol. 2004 Nov;97(5):1774-80.

Appl Physiol. 1999 Mar;86(3):970-6.

102 Lung Inflammation

Cell Mol Biol. 1994 Jan;10(1):16-23.

1996 Oct;271(4 Pt 1):L587-92.


[82] Mause SF, Weber C. Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ Res. 2010 Oct 29;107(9):1047-57.

[95] Godleski JJ, Verrier RL, Koutrakis P, Catalano P, Coull B, Reinisch U, et al. Mecha‐ nisms of morbidity and mortality from exposure to ambient air particles. Res Rep

Nature and Consequences of the Systemic Inflammatory Response Induced by Lung Inflammation

http://dx.doi.org/10.5772/57392

105

[96] Nemmar A, Hoet PH, Vanquickenborne B, Dinsdale D, Thomeer M, Hoylaerts MF, et al. Passage of inhaled particles into the blood circulation in humans. Circulation.

[97] Peters A, Veronesi B, Calderon-Garciduenas L, Gehr P, Chen LC, Geiser M, et al. Translocation and potential neurological effects of fine and ultrafine particles a criti‐

[98] Fry DE. Sepsis, systemic inflammatory response, and multiple organ dysfunction: the

[99] Suwa T, Hogg JC, Quinlan KB, Ohgami A, Vincent R, van Eeden SF. Particulate air pollution induces progression of atherosclerosis. J Am Coll Cardiol. 2002 Mar

[100] Sun Q, Wang A, Jin X, Natanzon A, Duquaine D, Brook RD, et al. Long-term air pol‐ lution exposure and acceleration of atherosclerosis and vascular inflammation in an

[101] Yatera K, Hsieh J, Hogg JC, Tranfield E, Suzuki H, Shih CH, et al. Particulate matter air pollution exposure promotes recruitment of monocytes into atherosclerotic pla‐

[102] Tamagawa E, Bai N, Morimoto K, Gray C, Mui T, Yatera K, et al. Particulate matter exposure induces persistent lung inflammation and endothelial dysfunction. Am J

[103] van Eeden SF, Sin DD. Chronic obstructive pulmonary disease: a chronic systemic in‐

[104] Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-anal‐

[105] Wedzicha JA, Seemungal TA, MacCallum PK, Paul EA, Donaldson GC, Bhowmik A, et al. Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels. Thromb Haemost. 2000

[106] Karadag F, Karul AB, Cildag O, Yilmaz M, Ozcan H. Biomarkers of systemic inflam‐ mation in stable and exacerbation phases of COPD. Lung. 2008 Nov-Dec;186(6):403-9.

[107] Sin DD, Wu L, Man SF. The relationship between reduced lung function and cardio‐ vascular mortality: a population-based study and a systematic review of the litera‐

Health Eff Inst. 2000 Feb(91):5-88; discussion 9-103.

cal update. Part Fibre Toxicol. 2006;3:13.

mystery continues. Am Surg. 2012 Jan;78(1):1-8.

animal model. JAMA. 2005 Dec 21;294(23):3003-10.

Physiol Lung Cell Mol Physiol. 2008 Jul;295(1):L79-85.

flammatory disease. Respiration. 2008;75(2):224-38.

ysis. Thorax. 2004 Jul;59(7):574-80.

ture. Chest. 2005 Jun;127(6):1952-9.

Aug;84(2):210-5.

ques. Am J Physiol Heart Circ Physiol. 2008 Feb;294(2):H944-53.

2002 Jan 29;105(4):411-4.

20;39(6):935-42.


[95] Godleski JJ, Verrier RL, Koutrakis P, Catalano P, Coull B, Reinisch U, et al. Mecha‐ nisms of morbidity and mortality from exposure to ambient air particles. Res Rep Health Eff Inst. 2000 Feb(91):5-88; discussion 9-103.

[82] Mause SF, Weber C. Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ Res. 2010 Oct 29;107(9):1047-57.

[83] Choi HS, Ashitate Y, Lee JH, Kim SH, Matsui A, Insin N, et al. Rapid translocation of nanoparticles from the lung airspaces to the body. Nat Biotechnol. 2010 Dec;28(12):

[84] Oberdorster G, Sharp Z, Atudorei V, Elder A, Gelein R, Lunts A, et al. Extrapulmona‐ ry translocation of ultrafine carbon particles following whole-body inhalation expo‐

[85] Morel O, Jesel L, Freyssinet JM, Toti F. Cellular mechanisms underlying the forma‐ tion of circulating microparticles. Arterioscler Thromb Vasc Biol. 2011 Jan;31(1):15-26.

[86] Amabile N, Rautou PE, Tedgui A, Boulanger CM. Microparticles: key protagonists in

[87] Boulanger CM, Amabile N, Tedgui A. Circulating microparticles: a potential prog‐ nostic marker for atherosclerotic vascular disease. Hypertension. 2006 Aug;48(2):

[88] Boulanger CM, Scoazec A, Ebrahimian T, Henry P, Mathieu E, Tedgui A, et al. Circu‐ lating microparticles from patients with myocardial infarction cause endothelial dys‐

[89] Thomashow MA, Shimbo D, Parikh MA, Hoffman EA, Vogel-Claussen J, Hueper K, et al. Endothelial microparticles in mild chronic obstructive pulmonary disease and emphysema. The Multi-Ethnic Study of Atherosclerosis Chronic Obstructive Pulmo‐

[90] Takahashi T, Kobayashi S, Fujino N, Suzuki T, Ota C, He M, et al. Increased circulat‐ ing endothelial microparticles in COPD patients: a potential biomarker for COPD ex‐

[91] Guiducci S, Distler JH, Jungel A, Huscher D, Huber LC, Michel BA, et al. The rela‐ tionship between plasma microparticles and disease manifestations in patients with

[92] van Eeden SF, de Beer P. Community-acquired pneumonia: evidence of functional inactivation of alpha 1 proteinase inhibitor. Crit Care Med. 1990 Nov;18(11):1204-9.

[93] Tamagawa E, Suda K, Wei Y, Xing L, Mui T, Li Y, et al. Endotoxin-induced transloca‐ tion of interleukin-6 from lungs to the systemic circulation. Innate Immun. 2009 Aug;

[94] Kido T, Tamagawa E, Bai N, Suda K, Yang HH, Li Y, et al. Particulate matter induces translocation of IL-6 from the lung to the systemic circulation. Am J Respir Cell Mol

nary Disease study. Am J Respir Crit Care Med. 2013 Jul 1;188(1):60-8.

acerbation susceptibility. Thorax. 2012 Dec;67(12):1067-74.

systemic sclerosis. Arthritis Rheum. 2008 Sep;58(9):2845-53.

cardiovascular disorders. Semin Thromb Hemost. 2010 Nov;36(8):907-16.

function. Circulation. 2001 Nov 27;104(22):2649-52.

sure of rats. J Toxicol Environ Health A. 2002 Oct 25;65(20):1531-43.

1300-3.

104 Lung Inflammation

180-6.

15(4):251-8.

Biol. 2011 Feb;44(2):197-204.


[108] Engelhart MJ, Geerlings MI, Meijer J, Kiliaan A, Ruitenberg A, van Swieten JC, et al. Inflammatory proteins in plasma and the risk of dementia: the rotterdam study. Arch Neurol. 2004 May;61(5):668-72.

[122] Quilez ME, Lopez-Aguilar J, Blanch L. Organ crosstalk during acute lung injury, acute respiratory distress syndrome, and mechanical ventilation. Curr Opin Crit

Nature and Consequences of the Systemic Inflammatory Response Induced by Lung Inflammation

http://dx.doi.org/10.5772/57392

107

[123] Ahuja N, Andres-Hernando A, Altmann C, Bhargava R, Bacalja J, Webb RG, et al. Circulating IL-6 mediates lung injury via CXCL1 production after acute kidney in‐

[124] Zhang H, Neuhofer P, Song L, Rabe B, Lesina M, Kurkowski MU, et al. IL-6 transsignaling promotes pancreatitis-associated lung injury and lethality. J Clin Invest.

[125] Klut ME, Doerschuk CM, Van Eeden SF, Burns AR, Hogg JC. Activation of neutro‐ phils within pulmonary microvessels of rabbits exposed to cigarette smoke. Am J Re‐

[126] Klut ME, van Eeden SF, Whalen BA, Verburgt LM, English D, Hogg JC. Neutrophil activation and lung injury associated with chronic endotoxemia in rabbits. Exp Lung

[127] Lang JD, Hickman-Davis JM. One-hit, two-hit... is there really any benefit? Clin Exp

[128] Lee JS, Su X, Rackley C, Matthay MA, Gupta N. Priming with endotoxin increases acute lung injury in mice by enhancing the severity of lung endothelial injury. Anat

[129] Sato Y, van Eeden SF, English D, Hogg JC. Bacteremic pneumococcal pneumonia: bone marrow release and pulmonary sequestration of neutrophils. Crit Care Med.

[130] Sato Y, Van Eeden SF, English D, Hogg JC. Pulmonary sequestration of polymorpho‐ nuclear leukocytes released from bone marrow in bacteremic infection. Am J Physiol.

[131] Hogg JC. Why does airway inflammation persist after the smoking stops? Thorax.

[132] Carlsten C, Dybuncio A, Pui MM, Chan-Yeung M. Respiratory impairment and sys‐ temic inflammation in cedar asthmatics removed from exposure. PLoS One.

[133] Eichacker PQ, Parent C, Kalil A, Esposito C, Cui X, Banks SM, et al. Risk and the effi‐ cacy of antiinflammatory agents: retrospective and confirmatory studies of sepsis.

[134] Rennard SI, Fogarty C, Kelsen S, Long W, Ramsdell J, Allison J, et al. The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease.

Am J Respir Crit Care Med. 2002 Nov 1;166(9):1197-205.

Am J Respir Crit Care Med. 2007 May 1;175(9):926-34.

jury in mice. Am J Physiol Renal Physiol. 2012 Sep 15;303(6):F864-72.

Care. 2012 Feb;18(1):23-8.

2013 Mar 1;123(3):1019-31.

spir Cell Mol Biol. 1993 Jul;9(1):82-9.

Res. 1996 Jul-Aug;22(4):449-65.

Immunol. 2005 Aug;141(2):211-4.

1998 Mar;26(3):501-9.

2006 Feb;61(2):96-7.

2013;8(2):e57166.

1998 Aug;275(2 Pt 1):L255-61.

Rec (Hoboken). 2011 Jan;294(1):165-72.


[122] Quilez ME, Lopez-Aguilar J, Blanch L. Organ crosstalk during acute lung injury, acute respiratory distress syndrome, and mechanical ventilation. Curr Opin Crit Care. 2012 Feb;18(1):23-8.

[108] Engelhart MJ, Geerlings MI, Meijer J, Kiliaan A, Ruitenberg A, van Swieten JC, et al. Inflammatory proteins in plasma and the risk of dementia: the rotterdam study. Arch

[109] Borson S, Scanlan J, Friedman S, Zuhr E, Fields J, Aylward E, et al. Modeling the im‐ pact of COPD on the brain. Int J Chron Obstruct Pulmon Dis. 2008;3(3):429-34. [110] Agusti A, Morla M, Sauleda J, Saus C, Busquets X. NF-kappaB activation and iNOS upregulation in skeletal muscle of patients with COPD and low body weight. Thor‐

[111] Agusti AG, Sauleda J, Miralles C, Gomez C, Togores B, Sala E, et al. Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease. Am J Respir

[112] Schols AM, Slangen J, Volovics L, Wouters EF. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med.

[113] Agusti AG. Systemic effects of chronic obstructive pulmonary disease. Proc Am

[115] Rana JS, Mittleman MA, Sheikh J, Hu FB, Manson JE, Colditz GA, et al. Chronic ob‐ structive pulmonary disease, asthma, and risk of type 2 diabetes in women. Diabetes

[116] Fahy JV. Eosinophilic and neutrophilic inflammation in asthma: insights from clinical

[117] Warwick G, Thomas PS, Yates DH. Non-invasive biomarkers in exacerbations of ob‐

[118] Kato M, Yamada Y, Maruyama K, Hayashi Y. Serum eosinophil cationic protein and 27 cytokines/chemokines in acute exacerbation of childhood asthma. Int Arch Aller‐

[119] Martinet Y, Rom WN, Grotendorst GR, Martin GR, Crystal RG. Exaggerated sponta‐ neous release of platelet-derived growth factor by alveolar macrophages from pa‐ tients with idiopathic pulmonary fibrosis. N Engl J Med. 1987 Jul 23;317(4):202-9. [120] Wynn TA. Integrating mechanisms of pulmonary fibrosis. J Exp Med. 2011 Jul

[121] Doi K, Ishizu T, Fujita T, Noiri E. Lung injury following acute kidney injury: kidney-

[114] Biskobing DM. COPD and osteoporosis. Chest. 2002 Feb;121(2):609-20.

Neurol. 2004 May;61(5):668-72.

106 Lung Inflammation

ax. 2004 Jun;59(6):483-7.

1998 Jun;157(6 Pt 1):1791-7.

Care. 2004 Oct;27(10):2478-84.

gy Immunol. 2010;152 Suppl 1:62-6.

4;208(7):1339-50.

Crit Care Med. 2002 Aug 15;166(4):485-9.

Thorac Soc. 2005;2(4):367-70; discussion 71-2.

studies. Proc Am Thorac Soc. 2009 May 1;6(3):256-9.

structive lung disease. Respirology. 2013 Jul;18(5):874-84.

lung crosstalk. Clin Exp Nephrol. 2011 Aug;15(4):464-70.


[135] Buff SM, Yu H, McCall JN, Caldwell SM, Ferkol TW, Flotte TR, et al. IL-10 delivery by AAV5 vector attenuates inflammation in mice with Pseudomonas pneumonia. Gene Ther. 2010 May;17(5):567-76.

ent particulate matter (PM(10)) air pollution. Am J Physiol Lung Cell Mol Physiol.

Nature and Consequences of the Systemic Inflammatory Response Induced by Lung Inflammation

http://dx.doi.org/10.5772/57392

109

[149] Miyata R, Bai N, Vincent R, Sin DD, Van Eeden SF. Statins reduce ambient particu‐ late matter-induced lung inflammation by promoting the clearance of particulate

[150] Chalmers JD, Singanayagam A, Murray MP, Hill AT. Prior statin use is associated with improved outcomes in community-acquired pneumonia. Am J Med. 2008 Nov;

[151] Mortensen EM, Restrepo MI, Anzueto A, Pugh J. The effect of prior statin use on 30 day mortality for patients hospitalized with community-acquired pneumonia. Respir

[152] Thomsen RW, Riis A, Kornum JB, Christensen S, Johnsen SP, Sorensen HT. Pread‐ mission use of statins and outcomes after hospitalization with pneumonia: popula‐ tion-based cohort study of 29,900 patients. Arch Intern Med. 2008 Oct 27;168(19):

[153] Blamoun AI, Batty GN, DeBari VA, Rashid AO, Sheikh M, Khan MA. Statins may re‐ duce episodes of exacerbation and the requirement for intubation in patients with COPD: evidence from a retrospective cohort study. Int J Clin Pract. 2008 Sep;62(9):

[154] Frost FJ, Petersen H, Tollestrup K, Skipper B. Influenza and COPD mortality protec‐ tion as pleiotropic, dose-dependent effects of statins. Chest. 2007 Apr;131(4):1006-12.

[155] Ishida W, Kajiwara T, Ishii M, Fujiwara F, Taneichi H, Takebe N, et al. Decrease in mortality rate of chronic obstructive pulmonary disease (COPD) with statin use: a

population-based analysis in Japan. Tohoku J Exp Med. 2007 Jul;212(3):265-73. [156] Keddissi JI, Younis WG, Chbeir EA, Daher NN, Dernaika TA, Kinasewitz GT. The use of statins and lung function in current and former smokers. Chest. 2007 Dec;

[157] Lee TM, Lin MS, Chang NC. Usefulness of C-reactive protein and interleukin-6 as predictors of outcomes in patients with chronic obstructive pulmonary disease re‐

[158] Mancini GB, Etminan M, Zhang B, Levesque LE, FitzGerald JM, Brophy JM. Reduc‐ tion of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary

[159] Soyseth V, Brekke PH, Smith P, Omland T. Statin use is associated with reduced

[160] Melbye H, Halvorsen DS, Hartz I, Medbo A, Brox J, Eggen AE, et al. Bronchial air‐ flow limitation, smoking, body mass index, and statin use are strongly associated

ceiving pravastatin. Am J Cardiol. 2008 Feb 15;101(4):530-5.

disease. J Am Coll Cardiol. 2006 Jun 20;47(12):2554-60.

mortality in COPD. Eur Respir J. 2007 Feb;29(2):279-83.

matter, < 10 mum from lung tissues. Chest. 2013 Feb 1;143(2):452-60.

2012 Sep 15;303(6):L492-9.

121(11):1002-7 e1.

Res. 2005;6:82.

2081-7.

1373-8.

132(6):1764-71.


ent particulate matter (PM(10)) air pollution. Am J Physiol Lung Cell Mol Physiol. 2012 Sep 15;303(6):L492-9.

[149] Miyata R, Bai N, Vincent R, Sin DD, Van Eeden SF. Statins reduce ambient particu‐ late matter-induced lung inflammation by promoting the clearance of particulate matter, < 10 mum from lung tissues. Chest. 2013 Feb 1;143(2):452-60.

[135] Buff SM, Yu H, McCall JN, Caldwell SM, Ferkol TW, Flotte TR, et al. IL-10 delivery by AAV5 vector attenuates inflammation in mice with Pseudomonas pneumonia.

[136] Sawa T, Corry DB, Gropper MA, Ohara M, Kurahashi K, Wiener-Kronish JP. IL-10 improves lung injury and survival in Pseudomonas aeruginosa pneumonia. J Immu‐

[137] Zuany-Amorim C, Haile S, Leduc D, Dumarey C, Huerre M, Vargaftig BB, et al. In‐ terleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensi‐

[138] Dokka S, Malanga CJ, Shi X, Chen F, Castranova V, Rojanasakul Y. Inhibition of en‐ dotoxin-induced lung inflammation by interleukin-10 gene transfer in mice. Am J

[139] Serhan CN. Novel lipid mediators and resolution mechanisms in acute inflamma‐

[140] Hsiao HM, Sapinoro RE, Thatcher TH, Croasdell A, Levy EP, Fulton RA, et al. A nov‐ el anti-inflammatory and pro-resolving role for resolvin D1 in acute cigarette smoke-

[141] Shahar E, Folsom AR, Melnick SL, Tockman MS, Comstock GW, Gennaro V, et al. Di‐ etary n-3 polyunsaturated fatty acids and smoking-related chronic obstructive pul‐ monary disease. Atherosclerosis Risk in Communities Study Investigators. N Engl J

[142] Jain MK, Ridker PM. Anti-inflammatory effects of statins: clinical evidence and basic

[143] Zhou Q, Liao JK. Pleiotropic effects of statins. - Basic research and clinical perspec‐

[144] Laufs U, Liao JK. Isoprenoid metabolism and the pleiotropic effects of statins. Curr

[145] Naidu BV, Woolley SM, Farivar AS, Thomas R, Fraga C, Mulligan MS. Simvastatin ameliorates injury in an experimental model of lung ischemia-reperfusion. J Thorac

[146] Fischetti F, Carretta R, Borotto G, Durigutto P, Bulla R, Meroni PL, et al. Fluvastatin treatment inhibits leucocyte adhesion and extravasation in models of complement-

[147] Jacobson JR, Barnard JW, Grigoryev DN, Ma SF, Tuder RM, Garcia JG. Simvastatin attenuates vascular leak and inflammation in murine inflammatory lung injury. Am J

[148] Miyata R, Bai N, Vincent R, Sin DD, Van Eeden SF. Novel properties of statins: sup‐ pression of the systemic and bone marrow responses induced by exposure to ambi‐

mediated acute inflammation. Clin Exp Immunol. 2004 Feb;135(2):186-93.

Gene Ther. 2010 May;17(5):567-76.

108 Lung Inflammation

nol. 1997 Sep 15;159(6):2858-66.

Med. 1994 Jul 28;331(4):228-33.

tives. Circ J. 2010 May;74(5):818-26.

Atheroscler Rep. 2003 Sep;5(5):372-8.

Cardiovasc Surg. 2003 Aug;126(2):482-9.

tized mice. J Clin Invest. 1995 Jun;95(6):2644-51.

Physiol Lung Cell Mol Physiol. 2000 Nov;279(5):L872-7.

tion: to resolve or not? Am J Pathol. 2010 Oct;177(4):1576-91.

induced lung inflammation. PLoS One. 2013;8(3):e58258.

mechanisms. Nat Rev Drug Discov. 2005 Dec;4(12):977-87.

Physiol Lung Cell Mol Physiol. 2005 Jun;288(6):L1026-32.


with the C-reactive protein level in the elderly. The Tromso Study 2001. Respir Med. 2007 Dec;101(12):2541-9.


with the C-reactive protein level in the elderly. The Tromso Study 2001. Respir Med.

[161] van Gestel YR, Hoeks SE, Sin DD, Simsek C, Welten GM, Schouten O, et al. Effect of statin therapy on mortality in patients with peripheral arterial disease and compari‐ son of those with versus without associated chronic obstructive pulmonary disease.

[162] van Eeden SF, Hogg JC. Systemic inflammatory response induced by particulate mat‐ ter air pollution: the importance of bone-marrow stimulation. J Toxicol Environ

[163] Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W, Jr., et al. A defi‐ nition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 1995 Sep 1;92(5):1355-74.

[164] Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W, Jr., Rosenfeld ME, et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, Ameri‐

[165] Guidelines for the evaluation of impairment/disability in patients with asthma. American Thoracic Society. Medical Section of the American Lung Association. Am

can Heart Association. Circulation. 1994 May;89(5):2462-78.

2007 Dec;101(12):2541-9.

110 Lung Inflammation

Am J Cardiol. 2008 Jul 15;102(2):192-6.

Health A. 2002 Oct 25;65(20):1597-613.

Rev Respir Dis. 1993 Apr;147(4):1056-61.
